Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
7.16 EUR
12.90 B EUR
40.52 B EUR
1.73 B
About Abbott Laboratories
Sector
Industry
CEO
Robert B. Ford
Website
Headquarters
Abbott Park
Founded
1888
FIGI
BBG01TNY9309
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Measured Move Target At 110Pretty simple analysis here:
touch of the bottom Keltner channel
potential weekly anti forming bearish
daily and weekly price action seem to deserve a second leg with the big surprise bear moves.
ABT long at 126.75 -- bad new is good news (for me)ABT got some bad news today when a Missouri judge ruled there would be a retrlal regarding a court case involving ABT's baby formula, and the stock, which was already down 3 days in a row, got thumped. While I don't dismiss long term risk from that news, I'm not in this for the long haul. I will l
$ABT : Reversal Pattern Just Dropped – Is $115 the NextAlright, let’s check out ABT on the daily chart. The stock enjoyed a steady climb since Jan 2025, riding a clear uptrend line, and now just nailed a technical reversal pattern, and it seems like it’s aiming for a target around $115 per share in the short term (1-3 months).
Abbott Hitting its Top. ABTRSX Divergence and crosses on volatility and stochastic indicators below. A strong change in flavor of candlesticks now, despite no cross of MIDAS. This one has been climbing for quite a bit, and now it might be time for a correction if just a temporary one.
Abbott Laboratories | ABT | Long at $110.00Abbott Laboratories NYSE:ABT has been making higher highs and lower lows over the last year, potentially signaling a reversal in its downward trend. Monkeypox and the return of cold/flu/COVID season may spark another run to close the price gap on the daily chart around $140. It is currently in a p
Abbott and Amazon: Two Bright Spots in a Sea of Red◉ Abbott Laboratories NYSE:ABT
● The stock previously faced strong resistance near the $134 level, leading to an extended consolidation phase.
● During this period, a Rounding Bottom pattern emerged, signalling a potential continuation of the upward trend.
● Following a recent breakout, the stoc
ABT Bullish Momentum – Move Toward $141.60 ExpectedNYSE:ABT is showing strong bullish momentum, trading within an ascending channel and steadily approaching the upper boundary. The recent price action highlights consistent buying pressure, suggesting a potential continuation toward the $141.60 level.
The stock has maintained its position above key
Abbott LabAbbott Lab : Anticipate upside move because of Cup and handle pattern is slowly appearing.
Abbott Laboratories : Check for long positionABT : Look for long position
If the current price crosses the 133 mark, then anticipate the price to move up to 142.
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Curated watchlists where 1ABT is featured.
Related stocks
Frequently Asked Questions
The current price of 1ABT is 116.08 EUR — it has increased by 1.49% in the past 24 hours. Watch ABBOTT LAB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange ABBOTT LAB stocks are traded under the ticker 1ABT.
1ABT stock has risen by 1.52% compared to the previous week, the month change is a 1.52% rise, over the last year ABBOTT LAB has showed a 1.52% increase.
We've gathered analysts' opinions on ABBOTT LAB future price: according to them, 1ABT price has a max estimate of 138.14 EUR and a min estimate of 110.34 EUR. Watch 1ABT chart and read a more detailed ABBOTT LAB stock forecast: see what analysts think of ABBOTT LAB and suggest that you do with its stocks.
1ABT reached its all-time high on May 2, 2025 with the price of 116.08 EUR, and its all-time low was 113.94 EUR and was reached on Apr 25, 2025. View more price dynamics on 1ABT chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1ABT stock is 1.46% volatile and has beta coefficient of 0.26. Track ABBOTT LAB stock price on the chart and check out the list of the most volatile stocks — is ABBOTT LAB there?
Yes, you can track ABBOTT LAB financials in yearly and quarterly reports right on TradingView.
ABBOTT LAB is going to release the next earnings report on Jul 17, 2025. Keep track of upcoming events with our Earnings Calendar.
1ABT earnings for the last quarter are 1.01 EUR per share, whereas the estimation was 0.99 EUR resulting in a 1.66% surprise. The estimated earnings for the next quarter are 1.11 EUR per share. See more details about ABBOTT LAB earnings.
ABBOTT LAB revenue for the last quarter amounts to 9.57 B EUR, despite the estimated figure of 9.62 B EUR. In the next quarter, revenue is expected to reach 9.79 B EUR.
1ABT net income for the last quarter is 1.20 B EUR, while the quarter before that showed 8.88 B EUR of net income which accounts for −86.47% change. Track more ABBOTT LAB financial stats to get the full picture.
Yes, 1ABT dividends are paid quarterly. The last dividend per share was 0.52 EUR. As of today, Dividend Yield (TTM)% is 1.72%. Tracking ABBOTT LAB dividends might help you take more informed decisions.
ABBOTT LAB dividend yield was 1.98% in 2024, and payout ratio reached 29.33%. The year before the numbers were 1.89% and 63.81% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 4, 2025, the company has 114 K employees. See our rating of the largest employees — is ABBOTT LAB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ABBOTT LAB EBITDA is 9.57 B EUR, and current EBITDA margin is 24.00%. See more stats in ABBOTT LAB financial statements.
Like other stocks, 1ABT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ABBOTT LAB stock right from TradingView charts — choose your broker and connect to your account.